Stay updated on Pembrolizumab in mCRPC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in mCRPC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in mCRPC Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Added a dedicated Locations section with California (San Francisco, CA) listed as a study site. The previous California Locations header was removed and the page revision updated to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T09:42:45.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    38 days ago
    Change Detected
    Summary
    Revision updated from v3.3.1 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-12-01T17:11:23.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.1, replacing Revision: v3.2.0. This update seems to be a technical version change with no impact on the study details or user-facing content.
    Difference
    0.1%
    Check dated 2025-11-24T14:37:23.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    Removed the government funding status notice that advised on open operations and where to check updates. The change does not affect trial details or outcomes.
    Difference
    0.4%
    Check dated 2025-11-17T06:54:54.000Z thumbnail image
  8. Check
    67 days ago
    Change Detected
    Summary
    Only visual formatting changes are visible; core study content such as title, eligibility criteria, endpoints, and results appears unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T01:18:45.000Z thumbnail image
  9. Check
    95 days ago
    Change Detected
    Summary
    Major update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.
    Difference
    2%
    Check dated 2025-10-05T09:53:24.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in mCRPC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in mCRPC Clinical Trial page.